Poly(ADP-ribosyl)ation of chromosomal proteins, epigenetic regulation and human genomic integrity in health and disease

Protein Reviews

Volumn 13, Issue , 2011, Pages 411-424

  Alvarez Gonzalez, Rafael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ADENOSINE DIPHOSPHATE RIBOSYLATION; AGING; APOPTOSIS; ARTHRITIS; CELL SURVIVAL; CHROMATIN; DIABETES MELLITUS; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; EPIGENETICS; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HISTONE MODIFICATION; HUMAN; HUMAN GENOME; NEOPLASM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA INTERACTION; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; STROKE; TRANSCRIPTION REGULATION;

EID: 77958454285     PISSN: 18713025     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6382-6_17     Document Type: Review

References (66)

1. Althaus, F. R. (1992). Poly ADP-ribosylation: a histone shuttle mechanism in DNA excision repair. J. Cell Sci. 102:663-670.
2. Alvarez-Gonzalez, R., Juarez-Salinas, H., Jacobson, E. L., et al. (1983). Evaluation of immobilized boronates for studies of adenine and pyridine nucleotide metabolism. Anal. Biochem. 135:69-77.
3. Alvarez-Gonzalez, R., and Jacobson, M. K. (1987). Characterization of polymers of adenosine diphosphate ribose generated in Vitro and in Vivo. Biochemistry 26:3218-3224.
4. Alvarez-Gonzalez, R. (1988). 3'-deoxyNAD as a substrate for poly (ADP-ribose) polymerase and the reaction mechanism of poly (ADP-ribose) elongation. J. Biol. Chem. 263:17690-17696.
5. Alvarez-Gonzalez, R. (ed) (1999). ADP-ribosylation reactions: from bacterial pathogenesis to cancer. Kluwer, Dordrecht/Boston/London.
6. Alvarez-Gonzalez, R., Spring, H., Muller, M., et al. (1999). Selective loss of poly (ADP-ribose) and the 85 kDa fragment of poly (ADP-ribose) polymerase in nucleoli during alkylationinduced apoptosis in HeLa cells. J. Biol. Chem. 274:32122-32126.
7. Alvarez-Gonzalez, R. (2001). PARP-regulation of eukaryotic gene expression. Survival or Death? Trends Genet. 17:607-608.
8. Alvarez-Gonzalez, R. (2007). Genomic maintenance: the p53 poly (ADP-ribosyl) ation connection. Sci. STKE (415): pe68.
9. Atorino, L., Alvarez-Gonzalez, R., Cardone, A., et al. (2000). Metabolic changes in the poly (ADP-ribosyl) ation pathway of differentiating rat germinal cells. Arch. Biochem. Biophys. 381:111-118.
10. Bartha, E., Kiss, G. N., Kalman, E., et al. (2008). Effect of L-2286, a poly (ADP-ribose) polymerase inhibitor and enalapril on myocardial remodeling and heart failure. J. Cardiovasc. Pharmacol. 52:253-261.
11. Beneke, S., and Burkle, A. (2007). Poly (ADP-ribosyl) ation in mammalian aging. Nucleic Acids Res. 35:7456-7465.
12. Benjamin, R. C., and Gill, D. M. (1980). ADP-ribosylation in mammalian cell ghosts. Dependence of poly (ADP-ribose) synthesis on strand breakage on DNA. J. Biol. Chem. 255:10493-10501.
13. Beard, W. A., and Wilson, S. H. (2006). Structure and mechanism of DNA polymerase beta. Chem. Rev. 106:361-382.
14. Booz, G. W. (2007). PARP inhibitors and heart failure. Translational medicine caught in the act. Congestive Heart Fail. 13:105-112.
15. Bouchard, V. J., Rouleau, M., Poirier, G. G. (2003). PARP-1, a determinant of cell survival in response to DNA damage. Exp. Hematol. 31:446-454.
16. Bromme, H. J., and Holtz, J. (1996). Apoptosis in the heart: when and why. Mol. Cell. Biochem. 163-164:261-275.
17. Chambon, P., Weill, J. D., Mandel, P. (1963). Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing enzyme. Biochem. Biophys. Res. Commun. 11:9-43.
18. Chang, W. J., and Alvarez-Gonzalez, R. (2001). The sequence specific DNA-binding of NF-κB is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase-1. J. Biol. Chem. 276:47664-47670.
19. Chatteerjee, S., Berger, S. J., Berger, N. A. (1999). Poly (ADP-ribose) polymerase: a guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Mol. Cell. Biochem. 193:23-30.
20. Choi, D. W. (1997). At the scene of ischemic brain injury. Is PARP a perp. Nature (Med) 3:1073-1074.
21. Conde, C., Mark, M., Oliver, F. J., Huber, A., et al. (2001). Loss of poly (ADP-ribose) polymerase 1 causes increased tumor latency in p53 deficient mice. EMBO J. 20:3535-3543.
22. Csiszar, A., Wang, M., Lakkata, E. G., et al. (2008). Inflammation and endothelial dysfunction during aging: role of NF-kappa B. J. Appl. Physiol. 105:1333-1341.
23. De Boer, R. A., van Veldhuisen, D. J., van der Wijk, J., et al. (2000). Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J. Card. Fail. 6:330-337.
24. Donawho, C. K., Luo, Y., Penning, T. D., et al. (2007). ABT-888, an orally active poly (ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in pre-clinical tumor models. Clin. Cancer Res. 13:2728-2737.
25. El-Domyati, M. M., Al-Din, A. B., Barakat, M. T., et al. (2008). Deoxyribonucleic acid repair and apoptosis in testicular germ cells of aging fertile men: the role of the poly (adenosine diphosphate ribosyl) ation pathway. Fertil. Steril. 91 (Suppl 5):2221-2229
26. Endres, M., Wang, Z. Q., Namura, S., et al. (1997). Ischemic brain injury is mediated by the activation by poly (ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 17:1143-1151.
27. Gospodinov, A., and Herceg, Z. (2009). Chromatin. The entry and exit from DNA repair. In: Vidal, C. J. (ed) Post-translational Modifications of Proteins, Springer, New York.
28. Grube, K., and Burkle, A. (1992). Poly (ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc. Natl. Acad. Sci. U. S. A. 89:11759-11763.
29. Haddad, M., Beray-Berthat, V., Coqueran, B., et al. (2008). Reduction of hemorrhagic transformation by PJ34, a poly (ADP-ribose) polymerase inhibitor after permanent focal cerebral ischemia in mice. Eur. J. Pharmacol. 588:52-57.
30. Hassa, P. O., Buerki, C., Lombardi, C., et al. (2003). Transcriptional co-activation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly (ADP-ribose) polymerase-1. J. Biol. Chem. 278:45145-45153.
31. Izzo, A., Kamieniarz, K., Schneider, R. (2008). The histone H1 family: specific members, specific functions? Biol. Chem. 389:333-343.
32. Jeoung, D., Lim, Y., Lee, E. B., et al. (2004). Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. J. Autoimmunity 22:87-94.
33. Joashi, U. C., Greenwood, K., Taylor, D. L., et al. (1999). Poly (ADP-ribose) polymerase cleavage precedes neuronal cell death in the hippocampus and cerebellum following injury to the development rat forebrain. Eur. J. Neurosci. 11:91-100.
34. Juarez-Salinas, H., Sims, J. L., Jacobson, M. K. (1979). Poly (ADP-ribose) levels in carcinogentreated cells. Nature (London) 282:740-741.
35. Kawaichi, K., Ueda, K., Hayaishi, O. (1981). Multiple autopoly (ADP-ribosyl) ation of rat liver poly (ADP-ribose) synthetase: Mode of modification and properties of automodified synthetase. J. Biol. Chem. 256:9483-9489.
36. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128:693-705.
37. Kumari, S. R., Alvarez-Gonzalez, R., Mendoza-Alvarez, H. (1998). Functional interactions of p53 with poly (ADP-ribose) polymerase (PARP) during apoptosis following DNA-damage: covalent poly (ADP-ribosyl) ation by exogenous PARP and non-covalent binding of p53 to Mr 85, 000 proteolytic fragment. Cancer Res. 58:5075-5078.
38. Lane, D. P. (1992). Cancer. p53-Guardian of the genome. Nature (London) 358:15-16.
39. Lindall, A. W., and Lazarow, L. (1964). A critical study of pyridine nucleotide concentrations in normal fed, normal fasted and diabetic rat liver. Metabolism 13:259-271.
40. Loetscher, P., Alvarez-Gonzalez, R., Althaus, F. R. (1987). Poly (ADP-ribose) may signal changing metabolic conditions to the chromatin of mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 84:1286-1289.
41. Malecka, K. A., Ho, W. C., Marmorstein, R. (2009). Crystal structure of a p53 core tetramer bound to DNA. Oncogene 28:325-333.
42. Masutani, M., Suzuki, H., Kamada, N., et al. (1999). Poly (ADP-ribose) polymerase gene disruption conferred mice resistant to streptosotocyn-induced diabetes. Proc. Natl. Acad. Sci. U. S. A. 96:2301-2304.
43. Mendoza-Alvarez, H., and Alvarez-Gonzalez, R. (1993). Poly (ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular. J. Biol. Chem. 268:22575-22580.
44. Mendoza-Alvarez, H., and Alvarez-Gonzalez, R. (2001). Regulation of p53 sequence-specific binding by covalent poly (ADP-ribosyl) ation. J. Biol. Chem. 276:36425-36430.
45. Mendoza-Alvarez, H., and Alvarez-Gonzalez, R. (1999). Biochemical characterization of mono (ADP-ribosyl) ated poly (ADP-ribose) polymerase. Biochemistry 38:3948-3953.
46. Messmer, U. K., Winkel, G., Briner, G. A., et al. (2000). Suppression of apoptosis by glucocorticoids in glomerulal endothelial cells: effects on proapoptotic pathways. Br. J. Pharmacol. 29:1673-1683.
47. Molnar. A., Toth, A., Bagi, Z., et al. (2006). Activation of the poly (ADP-ribose) polymerase pathway in human heart failure. Mol. Med. 12:143-152.
48. Moroni, F., and Chiarugi, A. (2009). Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment. FEBS J. 276:36-45.
49. Negri, C., Scovassi, A. I., Cerino, A., et al. (1990). Autoantibodies to poly (ADP-ribose) polymerase in autoimmune diseases. Autoimmunity 6:203-209.
50. Oliver, F. J., Menissier-de Murcia, J., Nacci, C., et al. (1999). Resistance to endotoxic shock as a consequence to defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18:4446-4454.
51. Okamoto, H. (1999). The CD38-cyclic ADP-ribose signaling system in insulin secretion. Mol. Cell. Biochem. 193:115-118.
52. Pacheco-Rodriguez, G., and Alvarez-Gonzalez, R. (1999). Measurement of poly (ADP-ribose) glycohydrolase activity by high resolution polyacrylamide gel electrophoresis: specific inhibition by histones and nuclear matrix proteins. Mol. Cell. Biochem. 193:13-18.
53. Pacher, P., and Szabo, C. (2008). Role of peroxynitrate-poly (ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 173:1-13.
54. Perkin, N. D., and Gilmore, T. D. (2006). Good cop, bad cop: the different faces of NF-kappa B. Cell Death Differ. 13:759-772.
55. Pietsch, E. C., Sykes, S. M., MacMahon, S. B., et al. (2008). The p53 family and programmed cell death. Oncogene 27:6507-6521.
56. Pillai, J. B., Isbatan, A., Imai, S. I., et al. (2005). Poly (ADP-ribose) polymerase 1-dependent cardiac myocyte cell death during heart failure is mediated by NAD + cell depletion and reduced Sir2α deacetylase activity. J. Biol. Chem. 280:43121-43130.
57. Plummer, R., Jones, C., Middleton, M., et al. (2008). Phase I study of the poly (ADP-ribose) polymerase inhibitor, AG-14699, in combination with temozolomide in patients with advanced solid tumors. Clin. Cancer. Res. 14:7917-7923.
58. Rosen, A., and Casciola-Rosen, L. (2004). Altered autoantigen structure in Sjogren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit. Rev. Oral Biol. Med. 15:156-164.
59. Scovassi, A. I., and Poirier, G. G. (1999). Poly (ADP-ribosyl) ation and apoptosis. Mol. Cell. Biochem. 199:125-137.
60. Simbulan-Rosenthal, C. M., Rosenthal, D. S., Luo, R. B., et al. (2001). Poly (ADP-ribosyl) ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence. Neoplasia 3:179-188.
61. Suganuma, T., and Workman, J. L. (2008). Crosstalk among histone modifications. Cell 135:604-607.
62. Tong, W. M., Cortes, U., Wang, Z. Q. (2001). Poly (ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. Biochim. Biophys. Acta 1552:27-37.
63. Tremethik, D. J. (2007). Higher-ordered structures of chromatin: the elusive 30 nm fiber. Cell 128:651-654.
64. Tye, B. K., and Swayer, S. (2000). The hexameric eukaryotic MCM helicase: building symmetry from non-identical parts. J. Biol. Chem. 275:34833-34836.
65. Valdor, R., Schreiber, V., Saenz, J., et al. (2008). Regulation of NFAT by poly (ADP-ribose) polymerase in T cells. Mol. Immunol. 24:1863-1871.
66. Wieler, S., Cagne, J. P., Vaziri, H., et al. (2003). Poly (ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 cycle arrest response following ionizing radiation. J. Biol. Chem. 278:18914-18921.